KBC Group’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
KBC Group's EXEL Position: Q3 2026 in Review
KBC Group increased its Exelixis (EXEL) stake by 3.7% in Q3 2026, buying an estimated $146K and bringing the position to 72,554 shares worth $4.24M. The position accounts for 0.01% of the portfolio, ranked #536.
KBC Group first reported a position in EXEL in Q4 2016 and has held it in 24 quarters since. The position peaked at $27.7M in Q2 2017. 381 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.
- KBC Group held 72,554 shares of Exelixis worth $4.24M as of Q3 2026.
- KBC Group bought 2,610 Exelixis shares in Q3 2026, an estimated $146K.
- Exelixis made up 0.01% of KBC Group's portfolio in Q3 2026, its #536 holding.
- KBC Group first reported a position in Exelixis in Q4 2016 and has held it in 24 quarters since.
- KBC Group's Exelixis position peaked at $27.7M in Q2 2017.
- 381 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.
Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.